# EDGAR Filing Document

**Accession Number:** 0002049248
**File Stem:** 0001929980-25-000681
**Filing Date:** 2025-10
**Character Count:** 94915
**Document Hash:** 57c9a75c363b2a3118cf4a6e24563be1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001929980-25-000681.hdr.sgml**: 20251028

**ACCESSION NUMBER**: 0001929980-25-000681

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 50

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251028

**DATE AS OF CHANGE**: 20251028

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Lakeshore Acquisition III Corp.
- **CENTRAL INDEX KEY:** 0002049248
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 000000000

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42623
- **FILM NUMBER:** 251425019

**BUSINESS ADDRESS:**
- **STREET 1:** 667 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10065
- **BUSINESS PHONE:** 917-327-9933

**MAIL ADDRESS:**
- **STREET 1:** 667 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10065

?xml version='1.0' encoding='ASCII'? lccc_10q.htm

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q**

(Mark One)

☒&nbsp;&nbsp;&nbsp;&nbsp; QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended **<u>September 30, 2025</u>**

☐&nbsp;&nbsp;&nbsp;&nbsp; TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________ to _______

Commission File Number: **<u>001-42623</u>**

---

| |
|:---|
| **Lakeshore Acquisition III Corp.** |
| (Exact name of registrant as specified in its charter) |

---

---

| | |
|:---|:---|
| **Cayman Islands** | **N/A** |
| (State or other jurisdiction of<br>incorporation or organization) | (I.R.S. Employer<br>Identification No.) |

---

---

| |
|:---|
| **<u>667 Madison Avenue, New York, NY, 10065</u>** |
| (Address of Principal Executive Offices, including zip code) |

---

---

| |
|:---|
| **<u>(917) 327-9933</u>** |
| (Registrant's telephone number, including area code) |

---

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Ordinary Shares | LCCC | THE NASDAQ STOCK MARKET LLC |
| Rights | LCCCR | THE NASDAQ STOCK MARKET LLC |
| Units | LCCCU | THE NASDAQ STOCK MARKET LLC |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes&nbsp;&nbsp;&nbsp;&nbsp; ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes&nbsp;&nbsp;&nbsp;&nbsp; ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| ☐  | Large accelerated filer | ☐ | Accelerated filer |
| ☒  | Non-accelerated filer | ☒  | Smaller reporting company |
|  |  | ☒ | Emerging growth company |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒&nbsp;&nbsp;&nbsp;&nbsp; No ☐

As of October 28, 2025 there were 8,905,000 ordinary shares, par value $0.0001, issued and outstanding.

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
| [PART I. FINANCIAL INFORMATION](#p1) | [PART I. FINANCIAL INFORMATION](#p1) | 3 |
| Item 1. | Condensed Financial Statements |  |
|  | [Unaudited Condensed Balance Sheet as of September 30, 2025 and Balance Sheet as of December 31, 2024](#bs) | 3 |
|  | [Unaudited Condensed Statements of Income for the three and nine months ended September 30, 2025](#op) | 4 |
|  | [Unaudited Condensed Statements of Changes in Shareholders' Equity (Deficit) for the three and nine months ended September 30, 2025](#eq) | 5 |
|  | [Unaudited Condensed Statement of Cash Flows for the nine months ended September 30, 2025](#cf) | 6 |
|  | [Notes to Unaudited Condensed Consolidated Financial Statements](#n) | 7 |
| [Item 2.](#i2) | [Management's Discussion and Analysis of Financial Condition and Results of Operations](#i2) | 19 |
| [Item 3.](#i3) | [Quantitative and Qualitative Disclosures About Market Risk](#i3) | 23 |
| [Item 4.](#i4) | [Controls and Procedures](#i4) | 23 |
| [PART II. OTHER INFORMATION](#p2) | [PART II. OTHER INFORMATION](#p2) | 24 |
| [Item 1.](#ii1) | [Legal Proceedings](#ii1) | 24 |
| [Item 1A.](#ii1a) | [Risk Factors](#ii1a) | 24 |
| [Item 2.](#ii2) | [Unregistered Sales of Equity Securities and Use of Proceeds](#ii2) | 24 |
| [Item 3.](#ii3) | [Defaults Upon Senior Securities](#ii3) | 24 |
| [Item 4.](#ii4) | [Mine Safety Disclosures](#ii4) | 24 |
| [Item 5.](#ii5) | [Other Information](#ii5) | 24 |
| [Item 6.](#ii6) | [Exhibits](#ii6) | 25 |
| [SIGNATURES](#sign) | [SIGNATURES](#sign) | 26 |

---

---

| |
|:---|
| 2 |
| *[**Table of Contents**](#toc)* |

---

**PART I – FINANCIAL INFORMATION**

**LAKESHORE ACQUISITION III CORP.**

**Condensed Balance Sheets**

---

| | | |
|:---|:---|:---|
|  | **September 30,**<br>**2025**<br>**Unaudited** |<br>**December 31,**<br>**2024** |
| **ASSETS** |  |  |
| **Current Assets** |  |  |
| Cash | $816656 | $100876 |
| Deferred offering costs |  | 195000 |
| Prepaid expenses | 33250 | 15000 |
| Total Current Assets | 849906 | 310876 |
| Marketable securities held in Trust Account | 70184641 | - |
| **Total Assets** | $71034547 | $310876 |
| **LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT)** |  |  |
| **Current Liabilities** |  |  |
| Notes payable to related party | $- | $300000 |
| Accrued expenses and other current liabilities | 75000 | - |
| Total Current Liabilities | 75000 | 300000 |
| Deferred underwriting fee payable  | 2415000 | - |
| **Total Liabilities** | 2490000 | 300000 |
| **Commitments and Contingencies (Note 6)** |  |  |
| Ordinary shares subject to possible redemption: 6,900,000 shares at redemption value of approximately $10.17 per share  | 70184641 | - |
| **Shareholders' Equity (Deficit)** |  |  |
| Ordinary shares, $0.0001 par value, 500,000,000 shares authorized, 2,005,000 and 1,725,000 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively <sup>(1)</sup> | 201 | 173 |
| Additional paid-in capital |  | 24827 |
| Accumulated deficit | (1640295) | (14124) |
| **Total Shareholders' Equity (Deficit)** | (1640094) | 10876 |
| **Total Liabilities and Shareholders' Equity (Deficit)** | $71034547 | $310876 |

---

(1) The number of ordinary shares issued and outstanding at December 31, 2024 includes an aggregate of 225,000 ordinary shares that are subject to forfeiture if the over-allotment option is not exercised. In connection with the closing of the initial public offering and the underwriters' full exercise of over-allotment option on May 1, 2025, the 225,000 shares were no longer subject to forfeiture.

The accompanying notes are an integral part of the unaudited condensed financial statements.

---

| |
|:---|
| 3 |
| *[**Table of Contents**](#toc)* |

---

**LAKESHORE ACQUISITION III CORP.**

**Unaudited Condensed Statements of Income**

---

| | | |
|:---|:---|:---|
|  | **For The** <br>**Three Months** <br>**Ended**<br>**September 30,** <br>**2025** | **For The** <br>**Nine Months** <br>**Ended**<br>**September 30,** <br>**2025** |
| Formation, general and administrative expenses | $230538 | $516070 |
| **Loss From Operations** | **(230538)** | **(516070)** |
| Other income |  |  |
| Interest income on marketable securities held in Trust Account | 717330 | 1184641 |
| **Net Income** | $**486792** | $**668571** |
| **Basic and diluted weighted average shares outstanding** |  |  |
| Redeemable ordinary shares-basic and diluted | 6900000 | 3867033 |
| Non-redeemable ordinary shares-basic and diluted <sup>(1)</sup> | 2005000 | 1783022 |
| **Basic and diluted net income (loss) per share** |  |  |
| Redeemable ordinary shares-basic and diluted | $0.08 | $0.22 |
| Non-redeemable ordinary shares-basic and diluted | $(0.03) | $(0.09) |

---

(1) The number of non-redeemable ordinary shares outstanding excludes an aggregate of 225,000 ordinary shares that are subject to forfeiture if the over-allotment option is not exercised for the period from January 1, 2025 through April 30, 2025. In connection with the closing of the initial public offering and the underwriters' full exercise of over-allotment option on May 1, 2025, the 225,000 shares were no longer subject to forfeiture. These shares were excluded from the calculation of weighted average shares outstanding until they were no longer subject to forfeiture.

The accompanying notes are an integral part of the unaudited condensed financial statements.

---

| |
|:---|
| 4 |
| *[**Table of Contents**](#toc)* |

---

**LAKESHORE ACQUISITION III CORP.**

**Unaudited Condensed Statement of Changes in Shareholders' Equity (Deficit)**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Ordinary Shares** | **Ordinary Shares** | | | |
|  | **Shares** | **Amount** | **Additional** <br>**Paid-in** <br>**Capital** | **Accumulated** <br>**Deficit** | **Total Shareholders' Equity** <br>**(Deficit)** |
| **Balances, December 31, 2024<sup>(1)</sup>** | **1725000** | $**173** | $**24827** | $**(14124)** | $**10876** |
| Net loss | - | - | - | (34688) | (34688) |
| **Balances, March 31, 2025<sup>(1)</sup>** | **1725000** | **173** | **24827** | **(48812)** | **(23812)** |
| Issuance of public units | 6900000 | 690 | 68999310 |  | 69000000 |
| Issuance of private units | 280000 | 28 | 2799972 |  | 2800000 |
| Deduction of offering costs |  |  | (3934900) |  | (3934900) |
| Deduction for value of public shares subject to possible redemption | (6900000) | (690) | (66991410) |  | (66992100) |
| Allocation of offering costs to public shares subject to possible redemption |  |  | 3820394 |  | 3820394 |
| Net income |  |  |  | 216467 | 216467 |
| Deduction for increases of carrying value of redeemable public shares | - | - | (4718193) | (1577412) | (6295605) |
| **Balances, June 30, 2025<sup>(1)</sup>** | **2005000** | **201** | **-** | **(1409757)** | **(1409556)** |
| Net income |  |  |  | 486792 | 486792 |
| Deduction for increases of carrying value of redeemable public shares | - | - | - | (717330) | (717330) |
| **Balances, September 30, 2025<sup>(1)</sup>** | **2005000** | $**201** | $**-** | $**(1640295)** | $**(1640094)** |

---

(1) The number of ordinary shares outstanding at December 31, 2024 and March 31, 2025 includes an aggregate of 225,000 ordinary shares that are subject to forfeiture if the over-allotment option is not exercised. In connection with the closing of the initial public offering and the underwriters' full exercise of over-allotment option on May 1, 2025, the 225,000 shares were no longer subject to forfeiture.

The accompanying notes are an integral part of the unaudited condensed financial statements.

---

| |
|:---|
| 5 |
| *[**Table of Contents**](#toc)* |

---

**LAKESHORE ACQUISITION III CORP.**

**Unaudited Condensed Statement of Cash Flows**

**For the Nine Months Ended September 30, 2025**

---

| | |
|:---|:---|
| **Cash flows from operating activities** |  |
| Net income | $668571 |
| Adjustments to reconcile net income to net cash used in operating activities: |  |
| Interest income earned in trust account  | (1184641) |
| Changes in operating assets and liabilities: |  |
| Increase in prepaid expenses | (18250) |
| Increase in accrued expenses | 75000 |
| **Net cash used in operating activities** | (459320) |
| **Cash flows from investing activities** |  |
| Cash deposited in trust account | (69000000) |
| **Net cash used in investing activities** | (69000000) |
| **Cash flows from financing activities** |  |
| Proceeds from issuance of public units | 69000000 |
| Proceeds from issuance of private units | 2800000 |
| Payment of underwriting fee | (1035000) |
| Payment of offering costs | (289900) |
| Repayment of the principal of promissory note to related party | (300000) |
| **Net cash provided by financing activities** | 70175100 |
| **Net increase in cash** | 715780 |
| Cash at beginning of period | 100876 |
| **Cash at end of period** | $816656 |
| **Non-cash financing activities** |  |
| Deferred underwriting commission charged to additional paid-in capital  | $2415000 |
| Initial value of public shares subject to possible redemption  | $66992100 |
| Reclassification of offering cost related to public shares  | $(3820394) |
| Subsequent measurement of public shares subject to possible redemption  | $7012935 |

---

The accompanying notes are an integral part of the unaudited condensed financial statements.

---

| |
|:---|
| 6 |
| *[**Table of Contents**](#toc)* |

---

**LAKESHORE ACQUISITION III CORP.**

**NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS**

**Note 1 — Organization and Business Operations**

Lakeshore Acquisition III Corp. (the "Company") was incorporated in the Cayman Islands on October 21, 2024, as a blank check company whose objective is to acquire, through a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The Company's efforts to identify a prospective target business will not be limited to any particular industry or geographic region.

As of September 30, 2025, the Company had not yet commenced any operations and had not generated revenue. All activities for the period from October 21, 2024 (inception) through September 30, 2025 relate to the Company's formation and the initial public offering (the "IPO") described below and the efforts for its initial business combination. The Company will not generate any operating revenue until after its initial business combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO. The Company has selected December 31 as its fiscal year-end.

The Company's sponsor is Redone Investment Limited, a BVI limited liability company.

***Financing***

The registration statement for the Company's IPO (as described in Note 3) was declared effective on April 29, 2025 (the "Effective Date"). On May 1, 2025, the Company consummated an IPO of 6,900,000 units, which includes the full exercise of the over-allotment option by the underwriters in the IPO, at $10.00 per unit (the "Public Units"), generating total gross proceeds of $69,000,000.

Simultaneously with the IPO, the Company sold to its sponsor 280,000 units at $10.00 per unit (the "Private Units") in a private placement (as described in Note 4), generating total gross proceeds of $2,800,000.

Offering costs amounted to $3,934,900, consisting of $1,035,000 of underwriting commissions, $2,415,000 of deferred underwriting commissions to be in the form of ordinary shares at $10.00 per share upon the consummation of the Company's initial business combination, and $484,900 of other offering costs. The Company received net proceeds of $70,280,100 from the IPO and the private placement without considering deferred underwriting commissions.

***Trust Account***

Upon the closing of the IPO and the private placement, $69,000,000 was placed in a trust account (the "Trust Account") with Wilmington Trust, National Association acting as trustee.

The funds held in the trust account can be invested in United States government treasury bills, notes or bonds having a maturity of 180 days or less or in money market funds meeting the applicable conditions under Rule 2a-7 promulgated under the Investment Company Act of 1940, as amended, until the earlier of the consummation of its first business combination and the Company's failure to consummate a business combination within 15 months from the consummation of the IPO.

Placing funds in the Trust Account may not protect those funds from third party claims against the Company. In addition, interest income earned on the funds in the Trust Account may be released to the Company to pay its income or other tax obligations. With these exceptions, expenses incurred by the Company may be paid prior to a business combination only from the net proceeds of the IPO and private placement not held in the Trust Account.

---

| |
|:---|
| 7 |
| *[**Table of Contents**](#toc)* |

---

***Business Combination***

Pursuant to Nasdaq listing rules, the Company's initial business combination may occur with one or more target businesses having an aggregate fair market value equal to at least 80% of the value of the funds in the Trust Account (excluding any taxes payable on the income earned on the Trust Account), which the Company refers to as the 80% test, at the time of the execution of a definitive agreement for its initial business combination, although the Company may structure a business combination with one or more target businesses whose fair market value significantly exceeds 80% of the Trust Account balance. If the Company is no longer listed on Nasdaq, it will not be required to satisfy the 80% test.

The Company currently anticipates structuring a business combination to acquire 100% of the equity interests or assets of the target business or businesses. The Company may, however, structure a business combination where the Company merges directly with the target business or where the Company acquires less than 100% of such interests or assets of the target business in order to meet certain objectives of the target management team or shareholders or for other reasons, but the Company will only complete such business combination if the post-transaction company owns 50% or more of the outstanding voting securities of the target or otherwise owns a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. If less than 100% of the equity interests or assets of a target business or businesses are owned or acquired by the post-transaction company, the portion of such business or businesses that is owned or acquired is what will be valued for purposes of the 80% test.

The Company will either seek shareholder approval of any business combination at a meeting called for such purpose at which shareholders may seek to convert their shares into their pro rata share of the aggregate amount then on deposit in the Trust Account, less any taxes then due but not yet paid, or provide shareholders with the opportunity to sell their shares to the Company by means of a tender offer for an amount equal to their pro rata share of the aggregate amount then on deposit in the Trust Account, less any taxes then due but not yet paid.

Notwithstanding the foregoing, a public shareholder, together with any affiliate of his or any other person with whom he is acting in concert or as a "group" (as defined in Section 13(d)(3) of the Exchange Act) will be restricted from seeking conversion rights with respect to 20% or more of the ordinary shares sold in this offering without the Company's prior written consent.

In connection with any shareholder vote required to approve any business combination, the initial shareholders will agree (a) to vote any of their respective shares in favor of the initial business combination and (ii) not to convert such respective shares into a pro rata portion of the Trust Account or seek to sell their shares in connection with any tender offer the Company engages in.

***Liquidation***

Pursuant to the amended and restated memorandum and articles of association, if the Company is unable to complete its initial business combination within 15 months from the effective date of the IPO, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than five business days thereafter, redeem 100% of the outstanding public shares at a price pro rata to the amount held in the Trust Account (less taxes payable and up to US$50,000 of interest to pay dissolution expenses) and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining holders of ordinary shares and the Company's board of directors, liquidate and dissolve.

***Liquidity and Capital Resources***

As of September 30, 2025, the Company had $816,656 in cash held outside its Trust Account available for the Company's working capital purposes.

The Company's liquidity needs prior to the consummation of the IPO had been satisfied through a payment from the sponsor of $25,000 (see Note 7) for the founder shares and the loan under an unsecured promissory note from the sponsor of $300,000 in total (see Note 5). Upon the consummation of the IPO, the $300,000 loan was repaid fully to the sponsor and no amounts were owed under the promissory note.

---

| |
|:---|
| 8 |
| *[**Table of Contents**](#toc)* |

---

Upon the consummation of the IPO with the over-allotment option fully exercised and the private placement (see Note 3 and Note 4), $69,000,000 of cash was placed in the Trust Account.

In order to meet its working capital needs following the consummation of the IPO, the Company's initial shareholders, officers and directors or their affiliates may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion. Each working capital loan would be evidenced by a promissory note and would either be paid upon consummation of the Company's initial business combination, without interest, or, at the lender's discretion, up to $1,000,000 of the working capital loan may be converted upon consummation of the Company's business combination into additional private units at a price of $10.00 per unit. If the Company does not complete a business combination, the working capital loan will only be repaid with funds not held in the trust account and only to the extent available (see Note 5). To date, there were no amounts outstanding under any working capital loans.

Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a business combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial business combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the business combination.

***Going Concern***

The Company performed an assessment on its ability to continue as a going concern in accordance with Financial Accounting Standard Board's Accounting Standards Update ("ASU") 2014-15, "Disclosures of Uncertainties about an Entity's Ability to Continue as a Going Concern". There is no assurance that the Company will be able to consummate the initial business combination within 15 months from the date of the IPO. In the event that the Company fails to consummate a business combination within the required period, the Company will face mandatory liquidation and dissolution subject to certain obligations under applicable laws or regulations. This uncertainty raises substantial doubt about the Company's ability to continue as a going concern one year from the date the financial statements are issued. No adjustments have been made to the carrying amounts of assets or liabilities regarding the possibility of the Company not continuing as a going concern, as a result of failing to consummate a business combination within 15 months from the date of the IPO. Management plans to continue its efforts to consummate a business combination within 15 months from the date of the IPO.

**Note 2 — Summary of Significant Accounting Policies**

***Basis of presentation***

The accompanying unaudited condensed financial statements are presented in U.S. Dollars and in conformity with accounting principles generally accepted in the United States of America ("GAAP") and pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three months and nine months ended September 30, 2025 are not necessarily indicative of the results that may be expected for the year ending December 31, 2025 or any future period.

The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form 8-K and the final prospectus filed by the Company with the SEC on May 7, 2025 and April 30, 2025, respectively.

---

| |
|:---|
| 9 |
| *[**Table of Contents**](#toc)* |

---

***Emerging Growth Company***

Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the "JOBS Act") permits emerging growth companies to delay complying with new or revised financial accounting standards that do not yet apply to private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act). The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company's financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

***Cash and Cash Equivalents***

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents as of September 30, 2025 and December 31, 2024.

***Offering Costs Associated with the IPO***

Offering costs consist of underwriting, legal, accounting, registration and other expenses incurred through the date of the closing of the IPO that are directly related to the IPO. As of May 1, 2025, offering costs totaled $3,934,900. The amount was consisted of $1,035,000 of underwriting commissions, $2,415,000 of deferred underwriting commissions (payment shall be in the form of ordinary shares at $10.00 per share deferred until consummation of the Company's initial business combination), and $484,900 of other offering costs. The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin ("SAB") Topic 5A – "Expenses of Offering". Offering costs were charged to shareholders' equity upon the completion of the IPO. The Company allocates offering costs between public shares and public rights based on the estimated fair values of them at the date of issuance. Accordingly, $3,820,394 was allocated to public shares and was charged to temporary equity; $114,506 was allocated to public rights and was charged to shareholders' equity.

***Ordinary Shares Subject to Possible Redemption***

The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 "Distinguishing Liabilities from Equity." Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company's control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders' equity. The Company's public shares feature certain redemption rights that are considered to be outside of the Company's control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption are presented at redemption value per share as temporary equity, outside of the shareholders' equity section of the Company's condensed balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid-in capital or accumulated deficit if additional paid-in capital equals to zero.

***Fair Value of Financial Instruments***

The fair value of the Company's assets and liabilities, which qualify as financial instruments under FASB ASC 820, "Fair Value Measurements and Disclosures," approximates the carrying amounts represented in the condensed balance sheet, primarily due to their short-term nature.

---

| |
|:---|
| 10 |
| *[**Table of Contents**](#toc)* |

---

***Fair Value Measurement***

Pursuant to FASB ASC 820, The fair value of the Company's financial assets and liabilities reflects management's estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

The following table presents information about the Company's assets that are measured at fair value on a recurring basis at September 30, 2025 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

---

| | | |
|:---|:---|:---|
| **Description** | **Level** | **September 30,** <br>**2025** |
| Assets: |  |  |
| Marketable securities held in Trust Account | 1 | $70184641 |

---

***Use of Estimates***

The preparation of the unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

***Concentration of Credit Risk***

Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times may exceed the federal depository insurance coverage of $250,000. As of September 30, 2025, $816,656 was deposited in cash accounts at Morgan Stanley. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

***Net Income (Loss) per Share***

The Company complies with accounting and disclosure requirements of FASB ASC 260, "Earnings Per Share". In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considers the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net income (loss) less interest income in trust account less any dividends paid. The company then allocates the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the ordinary shares subject to possible redemption is considered to be dividends paid to the public shareholders.

For the three months and nine months ended September 30, 2025, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the period presented. The calculation of diluted income (loss) per share does not consider the effect of the rights issued in connection with the IPO and the private placement since the conversion of rights to ordinary shares will be contingent on the occurrence of future events.

---

| |
|:---|
| 11 |
| *[**Table of Contents**](#toc)* |

---

The net income (loss) per share presented in the unaudited condensed statements of income is based on the following computation:

---

| | | |
|:---|:---|:---|
|  | **For The**<br>**Three Months** <br>**Ended**<br>**September 30,** <br>**2025** | **For the**<br>**Nine Months** <br>**Ended**<br>**September 30,** <br>**2025** |
| Net income | $486792 | $668571 |
| Interest earned from Trust Account | (717330) | (1184641) |
| Net loss allocable to both redeemable and nonredeemable shares | $(230538) | $(516070) |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For The Three Months Ended** | **For The Three Months Ended** | **For The Nine Months Ended** | **For The Nine Months Ended** |
|  | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
|  | **Redeemable** <br>**shares** | **Non-redeemable shares** | **Redeemable** <br>**shares** | **Non-redeemable shares** |
| Basic and diluted net income (loss) per share: |  |  |  |  |
| Numerators: |  |  |  |  |
| Allocation of net loss allocable to both redeemable and nonredeemable shares | $(178631) | $(51907) | $(353211) | $(162859) |
| Interest earned from Trust Account | 717330 | - | 1184641 | - |
| Allocation of net income (loss) | $538699 | $(51907) | $831430 | $(162859) |
| Denominators: |  |  |  |  |
| Weighted-average shares outstanding <sup>(1)</sup> | 6900000 | 2005000 | 3867033 | 1783022 |
| Basic and diluted net income (loss) per share | $0.08 | $(0.03) | $0.22 | $(0.09) |

---

(1) The number of non-redeemable ordinary shares outstanding excludes an aggregate of 225,000 ordinary shares that are subject to forfeiture if the over-allotment option is not exercised from the period from January 1, 2025 through April 30, 2025. In connection with the closing of the initial public offering and the underwriters' full exercise of over-allotment option on May 1, 2025, the 225,000 shares were no longer subject to forfeiture. These shares were excluded from the calculation of weighted average shares outstanding until they were no longer subject to forfeiture.

***Related Party Transactions***

Parties, which can be a corporation or individual, are considered to be related if one party has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operational decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

The Company identifies and discloses related party and related party transactions in accordance with ASC 850 Related Party Disclosures ("ASC 850") and guidance of SEC, including the nature of the relationship, the description of the transactions, the dollar amounts, and any outstanding balances.

---

| |
|:---|
| 12 |
| *[**Table of Contents**](#toc)* |

---

***Income Taxes***

The Company accounts for income taxes under ASC 740 Income Taxes ("ASC 740"). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements and prescribes a recognition threshold and measurement process for financial statements recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company has identified Cayman Islands as its only "major" tax jurisdiction, as defined. Based on the Company's evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company's financial statements. Since the Company was incorporated on October 21, 2024, the evaluation was performed for 2024 tax year which will be the only period subject to examination. The Company believes that its income tax positions and deductions would be sustained on audit and does not anticipate any adjustments that would result in a material change to its financial position. The Company's policy for recording interest and penalties associated with audits is to record such items as a component of income tax expense. There were no interest and penalties incurred since the Company was incorporated on October 21, 2024.

The Company may be subject to potential examination by foreign taxing authorities in the area of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with foreign tax laws.

The Company's tax provision was deemed to be de minimis for the period presented. The Company is considered to be an exempted Cayman Islands Company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States.

***Recent Accounting Pronouncements***

In November 2023, the FASB issued Accounting Standards Update ("ASU") 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures." The amendments in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating decision maker ("CODM"), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all annual disclosures currently required by Topic 280 in interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing segment disclosures in Topic 280. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company adopted ASU 2023-07 on January 1, 2025, as described in Note 8.

Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed financial statements.

**Note 3 — Initial Public Offering**

Pursuant to the IPO on May 1, 2025, the Company sold 6,900,000 Public Units, which includes the full exercise of the underwriters' over-allotment option, at a price of $10.00 per Public Unit. Each unit consists of one ordinary share and one right. Each right entitles the holder thereof to receive one-sixth of one ordinary share upon the consummation of an initial business combination. No fractional shares will be issued upon conversion of the rights (See Note 7).

---

| |
|:---|
| 13 |
| *[**Table of Contents**](#toc)* |

---

All of the 6,900,000 public shares sold as part of the Public Units in the IPO contain a redemption feature which allows for the redemption of such public shares if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company's amended and restated memorandum and articles of association, or in connection with the Company's liquidation. In accordance with the Securities and Exchange Commission (the "SEC") and its staff's guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require ordinary shares subject to redemption to be classified outside of permanent equity.

As of September 30, 2025, the ordinary shares subject to possible redemption reflected on the balance sheet are reconciled in the following table.

---

| | |
|:---|:---|
|  | **As of** <br>**September 30,** <br>**2025** |
| Gross proceeds | $69000000 |
| Less: |  |
| Proceeds allocated to public rights | (2007900) |
| Offering costs of public shares | (3820394) |
| Plus: |  |
| Accretion of carrying value to redemption value | 7012935 |
| Ordinary share subject to possible redemption | $70184641 |

---

**Note 4 — Private Placement**

Simultaneously with the closing of the IPO, Redone Investment Limited, the Company's sponsor, purchased an aggregate of 280,000 Private Units in a private placement at $10.00 per Private Unit. The Private Units are identical to the units sold in the IPO, as each private unit consists of one share of ordinary shares in the Company, and one right to receive one sixth (1/6) of a share of ordinary shares automatically upon the consummation of an initial business combination.

The holders of the private units have agreed (A) to vote the shares underlying their private units in favor of any proposed business combination, (B) not to propose, or vote in favor of, an amendment to the Company's amended and restated memorandum and articles of association with respect to the Company's pre-business combination activities prior to the consummation of such a business combination unless the Company provides public shareholders with the opportunity to convert their public shares in connection with any such vote, (C) not to convert any shares underlying the private units into the right to receive cash from the Trust Account in connection with a shareholder vote to approve an initial business combination or a vote to amend the provisions of the Company's amended and restated memorandum and articles of association relating to shareholders' rights or pre-business combination activity or sell their shares to the Company in connection with a tender offer the Company engages in and (D) that the shares underlying the private units shall not participate in any liquidating distribution upon winding up if a business combination is not consummated.

**Note 5 — Related Party Transactions**

***Founder Shares***

On November 6, 2024, 1,725,000 shares of the Company's ordinary shares were subscribed by the sponsor at a price of approximately $0.014 per share for an aggregate amount of $25,000, which includes an aggregate of 225,000 ordinary shares that are subject to forfeiture if the over-allotment option is not exercised. The per share purchase price of the founder shares was determined by dividing the amount of cash contributed to the company by the aggregate number of founder shares issued. The number of founder shares issued was determined based on the expectation that the founder shares would represent 20% of the outstanding shares after this offering (not including the shares underlying the private placement units or the shares to be issued to the underwriter at closing of the business combination). On May 1, 2025, the over-allotment option has been fully exercised. As a result, the 225,000 founder shares were no longer subject to forfeiture.

---

| |
|:---|
| 14 |
| *[**Table of Contents**](#toc)* |

---

***Administrative Service Fee***

The Company has agreed, commencing on the signing of the administrative services agreement with the sponsor on November 17, 2024, to pay the sponsor a monthly fee of up to $10,000 up to the consummation of business combination, for the Company's use of its personnel and other administrative resources. As of September 30, 2025, the Company had paid an aggregate of $104,000 to the sponsor.

***Related Party Loans***

On December 11, 2024, the Company issued a $300,000 principal amount unsecured promissory note to the Company's sponsor, and the Company had received such amount as of the issuance date. The note is non-interest bearing, and due after the date on which this offering is consummated or the Company determines to abandon this offering. On May 1, 2025, the $300,000 loan was repaid fully to the sponsor. No amounts were owed under the promissory note as of September 30, 2025.

As mentioned in Note 1, in order to meet its working capital needs following the consummation of the IPO, the Company's initial shareholders, officers and directors or their affiliates may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion. Each working capital loan would be evidenced by a promissory note and would either be paid upon consummation of the Company's initial business combination, without interest, or, at the lender's discretion, up to $1,000,000 of the working capital loan may be converted upon consummation of the Company's business combination into additional private units at a price of $10.00 per unit. If the Company does not complete a business combination, the working capital loan will only be repaid with funds not held in the Trust Account and only to the extent available.

***Other Related Party Transactions***

For the three months ended September 30, 2025, total reimbursement of out-of-pocket expenses paid to our sponsor, officers or directors were $8,840. For the nine months ended September 30, 2025, total reimbursement of out-of-pocket expenses paid to our sponsor, officers or directors were $26,946. The outstanding balance amount of unreimbursed expenses was nil at September 30, 2025 and December 31, 2024.

**Note 6 — Commitments and Contingencies**

***Risks and Uncertainties***

On August 16, 2022, the Inflation Reduction Act of 2022 (the "IR Act") was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic (i.e., U.S.) corporations and certain domestic subsidiaries of publicly traded foreign corporations. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from whom shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the "Treasury") has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. The IR Act applies to repurchases that occur after December 31, 2022.

Therefore, any redemption or other repurchase that occurs after December 31, 2022, in connection with a business combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a business combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the business combination, extension or otherwise, (ii) the structure of a business combination, (iii) the nature and amount of any "PIPE" or other equity issuances in connection with a business combination (or otherwise issued not in connection with a business combination but issued within the same taxable year of a business combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming shareholders, the mechanics of any required payments of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a business combination and in the Company's ability to complete a business combination.

---

| |
|:---|
| 15 |
| *[**Table of Contents**](#toc)* |

---

***Underwriting Agreement***

A deferred underwriting commission of $0.35 per Public Unit sold, totaling $2,415,000 will be in the form of representative shares at $10.00 per share deferred until consummation of the Company's initial business combination.

***Registration Rights***

The initial shareholders will be entitled to registration rights with respect to their initial shares, as well as the holders of the private units and holders of any securities issued to the Company's initial shareholders, officers, directors or their affiliates in payment of working capital loans or extension loans made to the Company, will be entitled to registration rights with respect to the private units (and underlying securities), pursuant to an agreement signed on the effective date of the IPO. The holders of such securities are entitled to demand that the Company register these securities at any time after the Company consummates a business combination. In addition, the holders have certain "piggy-back" registration rights on registration statements filed after the Company's consummation of a business combination.

***Engagement agreement with Legal Counsel***

The Company has entered into an engagement agreement with its legal counsel with respect to the initial business combination. The fee will be based on the number of hours spent. An aggregate of $150,000 will be paid prior to the closing of the business combination, and the balance will be due upon the closing of the business combination.

***Engagement Agreement – Fairness Opinion***

An aggregate of $30,000 will be paid prior to and upon the effectiveness of the registration statement of the initial business combination, based on an engagement agreement entered into by the Company and the provider of fairness opinion for the initial business combination.

***Engagement Agreement – Financial Advisory***

The Company has retained a financial advisor with respect to the initial business combination. An initial retainer of $150,000 was paid during the three months ended September 30, 2025. And the Company agrees to pay 500,000 newly issued shares of common stock at $10.00 per share at the closing of the business combination if the Company completes its initial business combination within 30 months from the engagement date.

**Note 7 — Shareholders' Deficit**

***Ordinary shares***

The Company is authorized to issue 500,000,000 ordinary shares with a par value of $0.0001 per share.

On November 6, 2024, 1,725,000 shares of the Company's ordinary shares were subscribed by the sponsor at a price of approximately $0.014 per share for an aggregate of $25,000, which includes an aggregate of 225,000 ordinary shares that are subject to forfeiture if the over-allotment option is not exercised. The per share purchase price of the founder shares was determined by dividing the amount of cash contributed to the company by the aggregate number of founder shares issued. The number of founder shares issued was determined based on the expectation that the founder shares would represent 20% of the outstanding shares after this offering (not including the shares underlying the private placement units or the shares to be issued to the underwriter at closing of the business combination). Since the over-allotment option was fully exercised, the 225,000 founder shares were no longer subject to forfeiture as of May 1, 2025.

---

| |
|:---|
| 16 |
| *[**Table of Contents**](#toc)* |

---

On May 1, 2025, the Company sold 6,900,000 Public Units, which includes the full exercise of the over-allotment option by the underwriters at a price of $10.00 per Public Unit in the IPO; and the Company sold to its sponsor an aggregate of 280,000 Private Units at $10.00 per Private Unit. Each Public Unit and Private Unit consists of one ordinary share and one right.

As of September 30, 2025, there were 2,005,000 shares of ordinary shares issued and outstanding, excluding 6,900,000 shares subject to possible redemption.

***Rights***

Each holder of a public right will automatically receive one-sixth of one ordinary share upon consummation of an initial business combination. The Company will not issue fractional shares in connection with an exchange of rights. Fractional shares will be rounded down to the nearest whole share. As a result, the holders of rights must hold rights in multiples of six in order to receive shares for all of their rights upon closing of a business combination. If the Company are unable to complete an initial business combination within the required time period and redeem the public shares for the funds held in the trust account, holders of rights will not receive any of such funds for their rights and the rights will expire worthless. If the Company enters into a definitive agreement for a business combination in which the Company will not be the surviving entity, the definitive agreement will provide for the holders of rights to receive the same per share consideration the holders of the ordinary share will receive in the transaction on an as-converted into ordinary share basis.

The private rights have terms and provisions identical to public rights except that they are subject to certain transfer restrictions as set forth by a letter agreement.

The Company accounted for the public and private rights issued in connection with the IPO and the private placement based on an assessment of the rights' specific terms and applicable guidance in ASC 480 and ASC 815.

The assessment considers whether the rights: (i) are freestanding financial instruments pursuant to ASC 480; (ii) meet the definition of a liability pursuant to ASC 480; and (iii) satisfy all requirements for equity classification under ASC 815, including whether the rights are indexed to the Company's own ordinary shares, and whether the right holders could potentially require "net cash settlement" in a circumstance outside of the Company's control, among other conditions for equity classification.

Based on this assessment, the public and private rights met the criteria for equity classification under ASC 815 as of their issuance date and are classified as equity.

**Note 8 —Segment Information**

ASC Topic 280, "Segment Reporting", establishes standards for companies to report, in their financial statements, information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise that engage in business activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is regularly evaluated by the Company's chief operating decision maker, or group, in deciding how to allocate resources and assess performance.

The Company's CODM has been identified as the Chief Executive Officer, who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one reportable segment.

---

| |
|:---|
| 17 |
| *[**Table of Contents**](#toc)* |

---

The CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported on the statements of income as net income or loss. The measure of segment assets is reported on the condensed balance sheet as total assets. When evaluating the Company's performance and making key decisions regarding resource allocation, the CODM reviews several key metrics, which include the following:

---

| | |
|:---|:---|
|  | **As of** <br>**September 30,** <br>**2025** |
| Cash | $816656 |
| Prepaid expenses | 33250 |
| Marketable securities held in Trust Account | 70184641 |
| **Total Assets** | $71034547 |

---

---

| | | |
|:---|:---|:---|
|  | **For The** <br>**Three Months** <br>**Ended**<br>**September 30,** <br>**2025** | **For The** <br>**Nine Months** <br>**Ended**<br>**September 30,** <br>**2025** |
| Formation, general and administrative expenses | $(230538) | $(516070) |
| Interest income on marketable securities held in Trust Account | 717330 | 1184641 |
| **Net Income** | $486792 | $668571 |

---

The CODM reviews the Company's financial position by reviewing the total assets available to determine if sufficient resources are in place to discharge liabilities. The CODM is provided with details of cash and liquid resources available with the Company. Additionally, the CODM regularly reviews the status of offering costs and general and administrative expenses incurred to assess if these are in line with the planned use of proceeds from the public offering.

**Note 9 —Subsequent Events**

The Company's management reviewed all material events that have occurred after the balance sheet date through the date which these unaudited condensed financial statements was issued. The Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

---

| |
|:---|
| 18 |
| *[**Table of Contents**](#toc)* |

---

**Item 2. Management's Discussion and Analysis.**

References to "we", "us", "our" or the "Company" are to Lakeshore Acquisition III Corp., except where the context requires otherwise. The following discussion should be read in conjunction with our unaudited Condensed Consolidated financial statements and related notes thereto included elsewhere in this report.

**Forward-Looking Statements**

This quarterly report on Form 10-Q includes forward-looking statements. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "should," "could," "would," "expect," "plan," "anticipate," "believe," "estimate," "continue," or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other Securities and Exchange Commission (the "SEC") filings.

**Overview**

We are a blank check company incorporated as a Cayman Islands exempted company on October 21, 2024, for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. Our efforts to identify a prospective target business will not be limited to a particular industry or geographic region. We intend to utilize cash derived from the proceeds of our initial public offering (the "IPO") in effecting our initial business combination.

We are an emerging growth company and, as such, we are subject to all of the risks associated with emerging growth companies.

We presently have no revenue. All activities for the period from October 21, 2024 (inception) through September 30, 2025 relate to the formation and the IPO and the efforts for the initial business combination. We will have no operations other than the active solicitation of one or more target businesses with which to complete a business combination, and we will not generate any operating revenue until after our initial business combination, at the earliest. We will have non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO.

On May 1, 2025, we consummated an IPO of 6,900,000 Public Units, which includes the underwriters' full exercise of the over-allotment option, at a price of $10.00 per Public Unit, generating gross proceeds of $69,000,000.

Simultaneously with the closing of the IPO, we consummated the sale of 280,000 Private Units, at a price of $10.00 per Private Unit, in a private placement to our sponsor, RedOne Investment Limited, generating gross proceeds of $2,800,000.

Offering costs amounted to $3,934,900, consisting of $1,035,000 of underwriting commissions, $2,415,000 of deferred underwriting commissions which will be in the form of ordinary shares at $10.00 per share upon the consummation of the Company's initial business combination, and $484,900 of other offering costs.

Upon the closing of the IPO and the private placement, $69,000,000 was placed in a trust account (the "Trust Account") with Wilmington Trust, National Association acting as trustee. This amount equals 6,900,000 ordinary shares subject to possible redemption multiplied by redemption value of $10.00 per share.

As indicated in the accompanying unaudited condensed financial statements, as of September 30, 2025, we had $816,656 in cash held outside the Trust Account available for working capital purposes.

**Results of Operations**

Our all activities from October 21, 2024 (inception) up to the consummation of the IPO was in preparation for the IPO.

Since the consummation of the IPO, our activities have been primarily focused on evaluating potential business combination candidates. We do not anticipate generating any operating revenues until the consummation of our initial business combination. We expect to generate non-operating income in the form of interest income from the proceeds derived from the IPO. We will incur expenses associated with being a public company, as well as costs related to the search for suitable business combination targets.

For the nine months ended September 30, 2025, we had a net income of $668,571. We incurred $516,070 of general and administrative expenses and earned $1,184,641 of interest income from investments in our Trust Account.

**Liquidity and Capital Resources**

As of September 30, 2025, we had $816,656 in cash held outside the Trust Account available for our working capital purposes.

---

| |
|:---|
| 19 |
| *[**Table of Contents**](#toc)* |

---

Prior to the consummation of the IPO, our liquidity needs had been satisfied through a payment from the sponsor of $25,000 for the founder shares, and the loan under an unsecured promissory note from the sponsor of $300,000. On May 1, 2025, the $300,000 loan was repaid fully to the sponsor and no amounts were owed under the promissory note.

We consummated the IPO and private placement on May 1, 2025. Upon the consummation of the IPO and the private placement, $69,000,000 of cash was placed in the Trust Account with Wilmington Trust, National Association acting as trustee. As of September 30, 2025, an aggregate of $70,184,641 was held in the Trust Account invested in U.S. treasury bills, notes or bonds having a maturity of 180 days or less or in money market funds meeting the applicable conditions under Rule 2a-7 promulgated under the Investment Company Act of 1940, as amend.

In order to meet our working capital needs following the consummation of the IPO, our initial shareholders, officers and directors or their affiliates may, but are not obligated to, loan us funds, from time to time or at any time, in amount they deem reasonable in their sole discretion. Each working capital loan would be evidenced by a promissory note and would either be paid upon consummation of our initial business combination, without interest, or, at the lender's discretion, up to $1,000,000 of the working capital loan may be converted upon consummation of our business combination into additional Private Units at a price of $10.00 per unit. If we do not complete a business combination, the working capital loan will only be repaid with funds not held in the Trust Account and only to the extent available. To date, there were no amounts outstanding under any working capital loans.

Based on the foregoing, management believes that we will have sufficient working capital and borrowing capacity to meet our needs through the earlier of the consummation of a business combination or one year from this filing. Over this time period, we will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial business combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the business combination.

If our estimates of the costs of undertaking due diligence and negotiating our initial business combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial business combination. Moreover, we may need to obtain additional financing either to consummate our initial business combination or because we become obligated to convert a significant number of our public shares upon consummation of our initial business combination, in which case we may issue additional securities or incur debt in connection with such business combination. Subject to compliance with applicable securities laws, we would only consummate such financing simultaneously with the consummation of our initial business combination. Following our initial business combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations.

We performed an assessment on our ability to continue as a going concern in accordance with Financial Accounting Standard Board's Accounting Standards Update ("ASU") 2014-15, "Disclosures of Uncertainties about an Entity's Ability to Continue as a Going Concern". There is no assurance that we will be able to consummate the initial business combination within 15 months from the date of the IPO. In the event that we fail to consummate a business combination within the required period, we will face mandatory liquidation and dissolution subject to certain obligations under applicable laws or regulations. This uncertainty raises substantial doubt about our ability to continue as a going concern one year from the date the financial statements are issued. No adjustments have been made to the carrying amounts of assets or liabilities regarding the possibility of us not continuing as a going concern, as a result of failing to consummate a business combination within 15 months from the date of the IPO. Management plans to continue its efforts to consummate a business combination within 15 months from the date of the IPO.

**Critical Accounting Policies**

The preparation of these unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements. Actual results could differ from those estimates.

---

| |
|:---|
| 20 |
| *[**Table of Contents**](#toc)* |

---

***Offering Costs Associated with the IPO***

Offering costs consist of underwriting, legal, accounting, registration and other expenses incurred through the date of the closing of the IPO that are directly related to the IPO. As of May 1, 2025, offering costs totaled $3,934,900. The amount was consisted of $1,035,000 of underwriting commissions, $2,415,000 of deferred underwriting commissions (payment shall be in the form of ordinary shares at $10.00 per share deferred until consummation of the Company's initial business combination), and $484,900 of other offering costs. We comply with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin ("SAB") Topic 5A – "Expenses of Offering". Offering costs were charged to shareholders' equity upon the completion of the IPO. We allocated offering costs between public shares and public rights based on the estimated fair values of them at the date of issuance. Accordingly, $3,820,394 was allocated to public shares and was charged to temporary equity; $114,506 was allocated to public rights and was charged to shareholders' equity.

***Ordinary Shares Subject to Possible Redemption***

We account for ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 "Distinguishing Liabilities from Equity." Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company's control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders' equity. Our public shares feature certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption are presented at redemption value per share as temporary equity, outside of the shareholders' equity section of our condensed balance sheet. We recognize changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid-in capital or accumulated deficit if additional paid-in capital equals to zero.

***Net Income (Loss) per Share***

We comply with accounting and disclosure requirements of FASB ASC 260, "Earnings Per Share". In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, we first consider the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net income (loss) less interest income in trust account less any dividends paid. We then allocate the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the ordinary shares subject to possible redemption is considered to be dividends paid to the public shareholders.

For the three months and nine months ended September 30, 2025, we did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of us. As a result, diluted income (loss) per share is the same as basic loss per share for the period presented. The calculation of diluted income (loss) per share does not consider the effect of the rights issued in connection with the IPO and the private placement since the conversion of rights to ordinary shares will be contingent on the occurrence of future events.

***Recent Accounting Standards***

In November 2023, the FASB issued Accounting Standards Update ("ASU") 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures." The amendments in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating decision maker ("CODM"), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all annual disclosures currently required by Topic 280 in interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing segment disclosures in Topic 280. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. We adopted ASU 2023-07 on January 1, 2025.

---

| |
|:---|
| 21 |
| *[**Table of Contents**](#toc)* |

---

Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed financial statements.

**Off-Balance Sheet Arrangements**

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of September 30, 2025. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

**Contractual Obligations**

***Underwriting Agreement***

A deferred underwriting commission of $0.35 per Public Unit sold, totaling $2,415,000 will be in the form of representative shares at $10.00 per share deferred until consummation of the initial business combination.

***Registration Rights***

The initial shareholders will be entitled to registration rights with respect to their initial shares, as well as the holders of the private units and holders of any securities issued to our initial shareholders, officers, directors or their affiliates in payment of working capital loans or extension loans made to us, will be entitled to registration rights with respect to the private units (and underlying securities), pursuant to an agreement signed on the effective date of the IPO. The holders of such securities are entitled to demand that we register these securities at any time after we consummate a business combination. In addition, the holders have certain "piggy-back" registration rights on registration statements filed after the consummation of a business combination.

***Engagement agreement with Legal Counsel***

We have entered into an engagement agreement with its legal counsel with respect to the initial business combination. The fee will be based on the number of hours spent. An aggregate of $150,000 will be paid prior to the closing of the business combination, and the balance will be due upon the closing of the business combination.

***Engagement Agreement – Fairness Opinion***

An aggregate of $30,000 will be paid prior to and upon the effectiveness of the registration statement of the initial business combination, based on an engagement agreement entered into by us with the provider of fairness opinion for the initial business combination.

***Engagement Agreement – Financial Advisory***

We have retained a financial advisor with respect to the initial business combination. An initial retainer of $150,000 was paid during the three months ended September 30, 2025. And we agree to pay 500,000 newly issued shares of common stock at $10.00 per share at the closing of the business combination if we complete the initial business combination within 30 months from the engagement date.

---

| |
|:---|
| 22 |
| *[**Table of Contents**](#toc)* |

---

**Item 3. Quantitative and Qualitative Disclosures About Market Risk**

Not required for smaller reporting companies.

**Item 4. Controls and Procedures**

***Evaluation of Disclosure Controls and Procedures***

Disclosure controls and procedures are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

As required by Rules 13a 15 and 15d 15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2025. Based upon this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that during the period covered by this report, our disclosure controls and procedures were effective.

***Changes in Internal Control over Financial Reporting***

There was no change in our internal control over financial reporting that occurred for the three months ended September 30, 2025, covered by this quarterly report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

---

| |
|:---|
| 23 |
| *[**Table of Contents**](#toc)* |

---

**PART II – OTHER INFORMATION**

**Item 1. Legal Proceedings**

None.

**Item 1A. Risk Factors**

Factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in our final prospectus on Form 424B4, dated as April 29, 2025. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, other than as described below, there have been no material changes to the risk factors disclosed in our final prospectus.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities**

On May 1, 2025, we consummated or initial public offering (the "IPO") of 6,900,000 units (the "Units"), which includes full exercise of the underwriter's over-allotment option. Each Unit consists of one ordinary share of the Company, par value $0.0001 per share (the "Ordinary Shares"), and one right that entitles the holder thereof to receive one-sixth (1/6) of one Ordinary Share upon consummation of our initial business combination (a "Right"). The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $69,000,000. The securities in the offering were registered under the Securities Act on a registration statement on Form S-1 (No. 333-286395). The SEC declared the registration statement effective on April 29, 2025.

Simultaneously with the closing of the IPO, we consummated a private placement (the "Private Placement") in which RedOne Investment Limited (the "Sponsor"), which purchased 280,000 private units (the "Private Units") at a price of $10.00 per Private Unit, generating total proceeds of $2,800,000. The issuances were made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. The Private Units are identical to the Public Units except with respect to certain registration rights and transfer restrictions.

We paid a total of $1,035,000 underwriting discounts and commissions and $484,900 for other offering costs and expenses related to the Initial Public Offering. In addition, the underwriters agreed to defer $2,415,000 in underwriting discounts and commissions, which will be in the form of ordinary shares at $10.00 per share upon the consummation of the Company's initial business combination.

A total of $69,000,000 of the proceeds from the IPO and the sale of the Private Placement Units was placed in a U.S.-based trust account at Wilmington Trust, National Association acting as trustee. $1,221,788 of cash was held outside of the Trust Account available for our working capital purposes.

For a description of the use of the proceeds generated in our Initial Public Offering, see Part I, Item 2 of this Quarterly Report.

**Item 3. Defaults Upon Senior Securities.**

None.

**Item 4. Mine Safety Disclosures.**

Not Applicable.

**Item 5. Other Information.**

None.

---

| |
|:---|
| 24 |
| *[**Table of Contents**](#toc)* |

---

**Item 6. Exhibits**

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

---

| | |
|:---|:---|
| **No.** | **Description of Exhibit** |
| [31.1](lccc_ex311.htm) | [Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](lccc_ex311.htm) |
| [31.2](lccc_ex312.htm) | [Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](lccc_ex312.htm) |
| [32.1\*](lccc_ex321.htm) | [Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](lccc_ex321.htm) |
| [32.2\*](lccc_ex322.htm) | [Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](lccc_ex322.htm) |
| 101.INS | Inline XBRL Instance Document |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB | Inline XBRL Taxonomy Extension Labels Linkbase Document |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 104 | Inline Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |

---

\* Furnished.

---

| |
|:---|
| 25 |
| *[**Table of Contents**](#toc)* |

---

**SIGNATURES**

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **Lakeshore Acquisition III Corp.** | **Lakeshore Acquisition III Corp.** |
| Date: October 28, 2025 | By: | */s/ Deyin (Bill) Chen* |
|  | Name:  | Deyin (Bill) Chen |
|  | Title: | Chief Executive Officer and Chief Financial Officer<br>(Principal Executive Officer, Principal Financial and Accounting Officer) |

---

## Exhibit 31.1

**EXHIBIT 31.1**

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER**

**PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Deyin (Bill) Chen, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Lakeshore Acquisition III Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and

b) (Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313);

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: October 28, 2025 |  |
|  | */s/ Deyin (Bill) Chen* |
|  | Deyin (Bill) Chen<br> Chief Executive Officer<br> (Principal Executive Officer) |

---

## Exhibit 31.2

**EXHIBIT 31.2**

**CERTIFICATION OF CHIEF FINANCIAL OFFICER**

**PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Deyin (Bill) Chen, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Lakeshore Acquisition III Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and

b) (Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313);

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: October 28, 2025 |  |
|  | */s/ Deyin (Bill) Chen* |
|  | Deyin (Bill) Chen<br> Chief Financial Officer<br> (Principal Financial and Accounting Officer) |

---

## Exhibit 32.1

**EXHIBIT 32.1**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Lakeshore Acquisition III Corp. (the "Company") on Form 10-Q for the quarterly period ended September 30, 2025, as filed with the Securities and Exchange Commission (the "Report"), I, Deyin (Bill) Chen, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | |
|:---|:---|
| Dated: October 28, 2025 |  |
|  | */s/ Deyin (Bill) Chen* |
|  | Deyin (Bill) Chen |
|  | Chief Executive Officer |
|  | (Principal Executive Officer) |

---

## Exhibit 32.2

**EXHIBIT 32.2**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Lakeshore Acquisition III Corp. (the "Company") on Form 10-Q for the quarterly period ended September 30, 2025, as filed with the Securities and Exchange Commission (the "Report"), I, Deyin (Bill) Chen, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | |
|:---|:---|
| Dated: October 28, 2025 |  |
|  | */s/ Deyin (Bill) Chen* |
|  | Deyin (Bill) Chen |
|  | Chief Financial Officer |
|  | (Principal Financial and Accounting Officer) |

---